Timothy J Barberich
CIK 1120355 · Executive Chairman · last filed 2023-12-21
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
SEPR price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
CONCORD, MA 01752
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TCRX | Director | 99,969 | $0.20 | $19.6K | $242.0K | 5 | 2023-12-21 |
| Korro Bio, Inc. (FREQ) Delisted | Director | 3,655 | $14.98 | $54.8K | $0 | 5 | 2022-08-19 |
| VSTM | Director | 18,167 | $9.97 | $181.1K | $813.6K | 13 | 2021-06-30 |
| ROCKET PHARMACEUTICALS, INC. (ITEK) Delisted | Director | — | — | — | $0 | 2 | 2017-06-21 |
| HeartWare International, Inc. (HTWR) Delisted | Director | 0 | — | — | $195.5K | 17 | 2016-08-24 |
| Eledon Pharmaceuticals, Inc. (TKAI) Delisted | Director | 13,453 | — | — | $0 | 3 | 2016-06-16 |
| BIOSPHERE MEDICAL INC (BSMD) Delisted | Director | 0 | — | — | $0 | 6 | 2010-09-10 |
| SEPRACOR INC /DE/ (SEPR) Delisted | Director | 526,598 | — | — | -$34.49M | 29 | 2009-10-19 |
Recent Filings · Page 9 of 9
85 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2007-06-07 | SEPRACOR INC /DE/ (SEPR) Delisted | Sell (S) | −19,200 | -$932.4K | EDGAR |
| 2007-06-07 | SEPRACOR INC /DE/ (SEPR) Delisted | Sell (S) | −21,800 | -$1.06M | EDGAR |
| 2007-05-17 | SEPRACOR INC /DE/ (SEPR) Delisted | Grant (A) | +17,500 | $933.6K | EDGAR |
| 2007-05-14 | BIOSPHERE MEDICAL INC (BSMD) Delisted | Grant (A) | +2,500 | $25 | EDGAR |
| 2007-03-09 | SEPRACOR INC /DE/ (SEPR) Delisted | Mixed | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.